WealthTrust Axiom’s Pulse Biosciences PLSE Stock Holding History

WealthTrust Axiom’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$464K	Hold	21,500	–	–	0.11%	151
2025 Q4	$295K	Hold	21,500	–	–	0.08%	197
2025 Q3	$381K	Hold	21,500	–	–	0.1%	168
2025 Q2	$324K	Hold	21,500	–	–	0.1%	174
2025 Q1	$346K	Hold	21,500	–	–	0.11%	173
2024 Q4	$374K	Hold	21,500	–	–	0.11%	170
2024 Q3	$377K	Hold	21,500	–	–	0.11%	166
2024 Q2	$241K	Hold	21,500	–	–	0.08%	200
2024 Q1	$187K	Hold	21,500	–	–	0.06%	232
2023 Q4	$263K	Hold	21,500	–	–	0.09%	191
2023 Q3	$86.6K	Hold	21,500	–	–	0.03%	225
2023 Q2	$155K	Hold	21,500	–	–	0.05%	227
2023 Q1	$72.2K	Hold	21,500	–	–	0.02%	231
2022 Q4	$59.6K	Buy	+21,500	New	+$48.3K	0.02%	230

Other funds holding PLSE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

GAM

Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

WealthTrust Axiom's PLSE Position: Q1 2026 in Review

WealthTrust Axiom held its Pulse Biosciences (PLSE) position steady in Q1 2026 at 21,500 shares worth $464K. The position accounts for 0.11% of the portfolio, ranked #151.

WealthTrust Axiom first reported a position in PLSE in Q4 2022 and has held it in 14 quarters since. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

WealthTrust Axiom held 21,500 shares of Pulse Biosciences worth $464K as of Q1 2026.
WealthTrust Axiom left its Pulse Biosciences share count unchanged in Q1 2026.
Pulse Biosciences made up 0.11% of WealthTrust Axiom's portfolio in Q1 2026, its #151 holding.
WealthTrust Axiom first reported a position in Pulse Biosciences in Q4 2022 and has held it in 14 quarters since.
96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on WealthTrust Axiom's 13F filing for Q1 2026, filed 11 May 2026.